Literature DB >> 17478783

Xp11 translocation carcinoma of the kidney presenting with multilocular cystic renal cell carcinoma-like features.

Sueli Suzigan1, Ricardo Drut, Paulo Faria, Pedram Argani, Angelo M De Marzo, Rui Nogueira Barbosa, Eliseu Roberto Mello Denadai, Júlio Martins-Filho, Rubens Carlos Martucci, Tufik Bauab.   

Abstract

Reported is the case of a 17-year-old girl with a multicystic tumor in the middle of the right kidney. Partial nephrectomy revealed an epithelial neoplasm with multilocular cystic renal cell carcinoma pattern. The cells exhibited strong nuclear reactivity for TFE3 protein and supported the diagnosis of Xp11 translocation carcinoma of the kidney. A similar case has not been found in the literature. The example emphasizes the high index of suspicion needed for an accurate diagnosis of renal carcinomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17478783     DOI: 10.1177/1066896906295891

Source DB:  PubMed          Journal:  Int J Surg Pathol        ISSN: 1066-8969            Impact factor:   1.271


  12 in total

1.  Laparoscopic radiofrequency ablation-assisted enucleation of Xp11.2 translocation renal cell carcinoma: A case report.

Authors:  Linfeng Xu; Rong Yang; Wei Wang; Yifen Zhang; Weidong Gan
Journal:  Oncol Lett       Date:  2014-06-18       Impact factor: 2.967

Review 2.  MiT family translocation renal cell carcinomas: A 15th anniversary update.

Authors:  Jatin S Gandhi; Faizan Malik; Mahul B Amin; Pedram Argani; Armita Bahrami
Journal:  Histol Histopathol       Date:  2019-09-06       Impact factor: 2.303

3.  Patterns of management of translocation renal cell carcinoma.

Authors:  Ali Al-Daghmin; Sohaib Alhamss; Khloud Al-Qasem; Hani Al-Najjar; Khaled Al-Smadi; Aseel Olaimat; Layana Al-Halbouni
Journal:  Turk J Urol       Date:  2018-11

4.  Usefulness of a break-apart FISH assay in the diagnosis of Xp11.2 translocation renal cell carcinoma.

Authors:  Soo Hee Kim; Yoomi Choi; Hae Yeon Jeong; Kyoungbun Lee; Ji Youn Chae; Kyung Chul Moon
Journal:  Virchows Arch       Date:  2011-07-20       Impact factor: 4.064

Review 5.  Renal cell carcinoma: Evolving and emerging subtypes.

Authors:  Suzanne M Crumley; Mukul Divatia; Luan Truong; Steven Shen; Alberto G Ayala; Jae Y Ro
Journal:  World J Clin Cases       Date:  2013-12-16       Impact factor: 1.337

6.  Establishment of an ASPL-TFE3 renal cell carcinoma cell line (S-TFE).

Authors:  Megumi Hirobe; Naoya Masumori; Toshiaki Tanaka; Hiroshi Kitamura; Taiji Tsukamoto
Journal:  Cancer Biol Ther       Date:  2013-06       Impact factor: 4.742

7.  Magnetic resonance imaging and computed tomography characteristics of renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion.

Authors:  Wei Wang; Jianhui Ding; Yuan Li; Chaofu Wang; Liangping Zhou; Hui Zhu; Weijun Peng
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

8.  Xp11.2 translocation renal cell carcinoma occurring during pregnancy with a novel translocation involving chromosome 19: a case report with review of the literature.

Authors:  Henry B Armah; Anil V Parwani; Urvashi Surti; Sheldon I Bastacky
Journal:  Diagn Pathol       Date:  2009-05-18       Impact factor: 2.644

9.  Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.

Authors:  Dinesh Pradhan; Somak Roy; Gabriela Quiroga-Garza; Kathleen Cieply; Alyssa L Mahaffey; Sheldon Bastacky; Rajiv Dhir; Anil V Parwani
Journal:  Diagn Pathol       Date:  2015-09-29       Impact factor: 2.644

10.  Measuring the improvement in health-related quality of life using King's health questionnaire in non-obese and obese patients with lower urinary tract symptoms after alpha-adrenergic medication: a preliminary study.

Authors:  Jae Heon Kim; Hoon Choi; Hwa Yeon Sun; Seung Whan Doo; Jong Hyun Yoon; Won Jae Yang; Byung Wook Yoo; Joyce Mary Kim; Soon-Sun Kwon; Eun Seop Song; Hong Jun Lee; Ik Sung Lim; Yun Seob Song
Journal:  BMC Urol       Date:  2014-08-06       Impact factor: 2.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.